E. Rio

784 total citations · 1 hit paper
42 papers, 523 citations indexed

About

E. Rio is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, E. Rio has authored 42 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 12 papers in Oncology. Recurrent topics in E. Rio's work include Advanced Radiotherapy Techniques (12 papers), Colorectal and Anal Carcinomas (8 papers) and Radiation Therapy and Dosimetry (8 papers). E. Rio is often cited by papers focused on Advanced Radiotherapy Techniques (12 papers), Colorectal and Anal Carcinomas (8 papers) and Radiation Therapy and Dosimetry (8 papers). E. Rio collaborates with scholars based in France, Canada and Australia. E. Rio's co-authors include F. Mornex, Marc-André Mahé, S. Supiot, Y. Pointreau, Berardino De Bari, P. Clavère, X. Mirabel, O. Malard, Thierry Conroy and Nicolás Ortonne and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

E. Rio

37 papers receiving 518 citations

Hit Papers

Total neoadjuvant therapy with mFOLFIRINOX versus preoper... 2024 2026 2025 2024 10 20 30 40 50
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial
    2024 57 citations Thierry Conroy, Florence Castan et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Rio France 12 243 225 163 150 120 42 523
Bin Qiu China 14 153 0.6× 124 0.6× 113 0.7× 104 0.7× 18 0.1× 40 398
Hedley Krawitz Australia 12 156 0.6× 195 0.9× 287 1.8× 79 0.5× 18 0.1× 24 560
Eli Sapir United States 9 97 0.4× 82 0.4× 165 1.0× 99 0.7× 34 0.3× 30 476
Naoya Ishibashi Japan 10 97 0.4× 127 0.6× 96 0.6× 63 0.4× 28 0.2× 72 377
V. Picardi Italy 13 196 0.8× 304 1.4× 231 1.4× 61 0.4× 11 0.1× 42 529
Carlos M. Araújo Brazil 12 305 1.3× 201 0.9× 494 3.0× 26 0.2× 29 0.2× 22 717
Cheng-Hsu Wang Taiwan 11 141 0.6× 316 1.4× 122 0.7× 65 0.4× 53 0.4× 20 513
Andrea Galuppi Italy 13 155 0.6× 161 0.7× 143 0.9× 63 0.4× 20 0.2× 41 442
Raul T. Meoz United States 12 193 0.8× 171 0.8× 134 0.8× 54 0.4× 18 0.1× 18 506
C.H. Paine United Kingdom 9 146 0.6× 124 0.6× 136 0.8× 38 0.3× 62 0.5× 24 427

Countries citing papers authored by E. Rio

Since Specialization
Citations

This map shows the geographic impact of E. Rio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Rio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Rio more than expected).

Fields of papers citing papers by E. Rio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Rio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Rio. The network helps show where E. Rio may publish in the future.

Co-authorship network of co-authors of E. Rio

This figure shows the co-authorship network connecting the top 25 collaborators of E. Rio. A scholar is included among the top collaborators of E. Rio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Rio. E. Rio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conroy, Thierry, Florence Castan, Pierre-Luc Etienne, et al.. (2024). Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial. Annals of Oncology. 35(10). 873–881. 57 indexed citations breakdown →
2.
3.
Hennequin, Christophe, E. Rio, L. Quéro, & P. Clavère. (2021). Radiation therapy of cutaneous cancers. Cancer/Radiothérapie. 26(1-2). 397–403. 6 indexed citations
4.
Blanc‐Onfroy, Magali Le, G. Delpon, E. Rio, et al.. (2021). Perineal recurrence of prostate cancer along a brachytherapy needle track: A case report. Cancer/Radiothérapie. 25(5). 476–479. 1 indexed citations
5.
Rio, E., et al.. (2021). Hepatic tumours and radiotherapy. Cancer/Radiothérapie. 26(1-2). 266–271. 4 indexed citations
6.
Peiffert, D., E. Rio, M.-A. Mahé, et al.. (2018). Radiothérapie conformationnelle avec modulation d’intensité des cancers du canal anal : impact de la délinéation sur le risque de récidive. Cancer/Radiothérapie. 22(6-7). 701–701. 1 indexed citations
7.
Bobin, Christophe, Pierre Ingrand, Brigitte Dréno, et al.. (2017). Prognostic factors for parotid metastasis of cutaneous squamous cell carcinoma of the head and neck. European Annals of Otorhinolaryngology Head and Neck Diseases. 135(2). 99–103. 16 indexed citations
8.
Paumier, A., P. Trémolières, M. Lacombe, et al.. (2016). Valeur pronostique du volume tumoral métabolique sur la TEP au (18F)-fluorodésoxyglucose préthérapeutique pour le cancer de l’œsophage localisé. Cancer/Radiothérapie. 20(1). 24–29. 2 indexed citations
9.
Hennequin, Christophe, E. Rio, & M.-A. Mahé. (2016). Radiothérapie des cancers cutanés. Cancer/Radiothérapie. 20. S249–S255. 10 indexed citations
10.
11.
12.
Mahé, Marc-André, et al.. (2014). Fonctions sexuelles après traitement du cancer rectal : impact des doses aux plexus pelviens autonomes. Cancer/Radiothérapie. 18(8). 757–762. 3 indexed citations
13.
Deutsch, Éric, C. Lemanski, Jean‐Pierre Pignon, et al.. (2013). Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial. Annals of Oncology. 24(11). 2834–2838. 60 indexed citations
14.
Bonerandi, J. J., Céline Beauvillain, V. Chaussade, et al.. (2011). Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. Journal of the European Academy of Dermatology and Venereology. 25(s5). 1–51. 117 indexed citations
15.
Mervoyer, A., et al.. (2010). Évaluation de la dose reçue par les organes à risque. Cancer/Radiothérapie. 14(4-5). 232–235. 4 indexed citations
16.
Rio, E., et al.. (2009). La curiethérapie interstitielle périoperatoire dans le traitement des cicatrices chéloïdes récidivantes. Cancer/Radiothérapie. 14(1). 65–68. 11 indexed citations
17.
18.
Supiot, S., F. Thillays, E. Rio, et al.. (2007). Le point sur les avancées récentes de la radio-immunothérapie alpha. Cancer/Radiothérapie. 11(5). 252–259. 4 indexed citations
19.
Rio, E., É. Bardet, C. Ferron, et al.. (2006). Curiethérapie interstitielle des cancers cutanés des zones périorificielles de la face. Cancer/Radiothérapie. 10(3). 101–106. 2 indexed citations
20.
Supiot, S., Jaafar Bennouna, E. Rio, et al.. (2006). Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer. Colorectal Disease. 8(5). 430–435. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bin Qiu Breakdown of academic impact, for papers by Hedley Krawitz Breakdown of academic impact, for papers by Eli Sapir Breakdown of academic impact, for papers by Naoya Ishibashi Breakdown of academic impact, for papers by V. Picardi Breakdown of academic impact, for papers by Carlos M. Araújo Breakdown of academic impact, for papers by Cheng-Hsu Wang Breakdown of academic impact, for papers by Andrea Galuppi Breakdown of academic impact, for papers by Raul T. Meoz Breakdown of academic impact, for papers by C.H. Paine
Rankless by CCL
2026